Free Trial

Anheuser-Busch InBev SA/NV (NYSE:BUD) Receives Consensus Rating of "Buy" from Analysts

Anheuser-Busch InBev SA/NV logo with Consumer Staples background

Shares of Anheuser-Busch InBev SA/NV (NYSE:BUD - Get Free Report) have earned a consensus rating of "Buy" from the ten research firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $71.50.

A number of equities research analysts recently issued reports on BUD shares. Deutsche Bank Aktiengesellschaft raised shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. Berenberg Bank assumed coverage on shares of Anheuser-Busch InBev SA/NV in a research note on Wednesday, April 2nd. They set a "buy" rating for the company. The Goldman Sachs Group raised shares of Anheuser-Busch InBev SA/NV from a "neutral" rating to a "buy" rating and increased their target price for the stock from $70.10 to $88.00 in a research note on Monday, May 12th. StockNews.com raised shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating in a research note on Saturday, May 10th. Finally, Argus raised shares of Anheuser-Busch InBev SA/NV from a "hold" rating to a "buy" rating and set a $70.00 target price for the company in a research note on Thursday, March 27th.

Get Our Latest Research Report on BUD

Anheuser-Busch InBev SA/NV Trading Down 0.0%

Shares of BUD opened at $67.51 on Friday. The company has a current ratio of 0.69, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. Anheuser-Busch InBev SA/NV has a 12-month low of $45.94 and a 12-month high of $67.60. The firm has a 50-day moving average price of $63.74 and a 200 day moving average price of $56.76. The firm has a market capitalization of $121.33 billion, a P/E ratio of 20.84, a P/E/G ratio of 1.73 and a beta of 0.83.

Anheuser-Busch InBev SA/NV (NYSE:BUD - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The consumer goods maker reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.77 by $0.04. Anheuser-Busch InBev SA/NV had a net margin of 10.98% and a return on equity of 15.29%. During the same period last year, the company earned $0.75 earnings per share. Anheuser-Busch InBev SA/NV's revenue was down 6.3% on a year-over-year basis. Sell-side analysts forecast that Anheuser-Busch InBev SA/NV will post 3.37 EPS for the current year.

Anheuser-Busch InBev SA/NV Increases Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Wednesday, May 7th will be paid a $1.0492 dividend. This is a positive change from Anheuser-Busch InBev SA/NV's previous annual dividend of $0.87. The ex-dividend date of this dividend is Wednesday, May 7th. This represents a dividend yield of 1.2%. Anheuser-Busch InBev SA/NV's dividend payout ratio (DPR) is presently 22.32%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in BUD. R Squared Ltd purchased a new position in shares of Anheuser-Busch InBev SA/NV in the fourth quarter valued at approximately $30,000. Rakuten Securities Inc. boosted its stake in shares of Anheuser-Busch InBev SA/NV by 2,722.7% in the fourth quarter. Rakuten Securities Inc. now owns 621 shares of the consumer goods maker's stock valued at $31,000 after purchasing an additional 599 shares during the period. NBC Securities Inc. purchased a new position in shares of Anheuser-Busch InBev SA/NV in the first quarter valued at approximately $32,000. Whipplewood Advisors LLC purchased a new position in shares of Anheuser-Busch InBev SA/NV in the fourth quarter valued at approximately $36,000. Finally, Garde Capital Inc. acquired a new stake in Anheuser-Busch InBev SA/NV in the first quarter valued at approximately $37,000. Hedge funds and other institutional investors own 5.53% of the company's stock.

Anheuser-Busch InBev SA/NV Company Profile

(Get Free Report

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.

See Also

Analyst Recommendations for Anheuser-Busch InBev SA/NV (NYSE:BUD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anheuser-Busch InBev SA/NV Right Now?

Before you consider Anheuser-Busch InBev SA/NV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anheuser-Busch InBev SA/NV wasn't on the list.

While Anheuser-Busch InBev SA/NV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines